Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-000256

CBO & COO gave up 9,392 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Klein Lawrence Otto CBO & COO 2021-01-02 Shares withheld for taxes −9,392 $153.11 $1,438,009 10,608 D: show line 1 in the form
Loading xslF345X03/doc4.xml…